PRKAA2 and acute lymphoblastic leukemia: Fortunately, my colleague Doreen Cantrell suggested an easier alternative, a mouse model of T-ALL (T cell acute lymphoblastic leukaemia/lymphoma), which required combining T cell-specific knockouts of the tumour suppressor PTEN and AMPK.